The future of clinical trials in the context of Brexit

Overview

Thank you for your participation in this survey, which asks you to share your views on exploring the critical factors that will shape the future of clinical trials out to 2028 in the context of Brexit.

The survey is in three parts and should take about 10-20 minutes to complete depending on the length of your answers.

First, you will be asked for your views on the factors shaping the future of clinical trials

We will then ask you what would you consider to be the critical factors for the future of clinical trials in the context of Brexit in the short (0-2 years) and long-term (5-10 years)

Finally, we will ask you to share any additional perspectives on the challenges and/or opportunities that you envisage as a result of Brexit, and what needs to be done today to ensure an optimal outcome.

We ask for some demographic information at the end of the survey to help with our analysis. However, all comments and responses will be kept confidential and unattributed and it will not be possible to identify individual respondents.

Context
Cancer Research UK (CRUK) is conducting a study exploring how the clinical trials landscape might evolve in the context of Brexit. This will inform our policy and influencing work as the UK and EU moves into phase 2 of negotiations.

CRUK are seeking the best possible outcome for clinical trials after the UK exits the EU. This includes close alignment between the UK and EU Clinical Trials Regulation, for the benefit of patients in the UK and the EU. While working towards this, CRUK have commissioned the School of International Futures to develop and explore scenarios for the future of clinical trials.

The survey is an early input into the project and aims to understand the key factors shaping the clinical trial landscape and their implications.

Invitations have been sent to individuals and organisations with an interest and expertise in Clinical Trials and the broader clinical research environment.

We hope that you will be able to take part. Please do pass on the invitation to additional colleagues with expertise in this area, or those who might be better placed to respond.

Contact information
For technical questions, please contact: Peter Glenday, peter@soif.org.uk.

If there are any questions concerning the project in general, please contact: Zoe Martin, zoe.martin@cancer.org.uk